BioByte 129: strategies to drug intrinsically disordered proteins , in silico prediction of RNA-LNP efficacy, and minibinder design to address multidrug-resistant bacterial infections

BioByte 128: metagenomic sequencing for biosurveillance, CIRTS remediate haploinsufficiency, TotalX scales single-cell RNA-sequencing, and The Diffuse Project seeks to unlock dynamic protein modeling

BioByte 127: Pleiades foundation models enable human epigenomic modelling, the release of CRISPR-GPT, the inflammatory connection between MS & Epstein-Barr, and character trait control in LLMs

BioByte 126: unveiling Latent-X, TrialMatchAI tackles matching patients to clinical trials, GLP-1s offer potential neuroprotective effects, and an outlook on molecular biosensors for trials

BioByte 125: decoding the regulome, merge-sort microfluidics, Ibex predictively models antibody conformational states, and targeting improvements for DNA-LNPs

BioByte 124: AUTOCT predicts clinical trial outcomes, liquid biopsy transforms cancer diagnostics, the ADIOS framework for designing antibodies, and a comprehensive mapping of off-target drug effects

BioByte 123: first steps toward a synthetic human genome, SDBench shows proficiency of language models for sequential diagnosis, Chai advances zero-shot antibody design, and the nuances of IC50s

BioByte 122: OpenAI postulates on AI's future capabilities in biology, STATE predicts cellular responses to perturbation, in vivo CAR T generation, and AlphaGenome tackles genetic predictions

BioByte 121: biology as the next software platform, language development in children, a massive Perturb-seq dataset, and morning coffee as a cancer treatment

BioByte 120: FutureHouse launches ether0, introducing Origene as a virtual disease biologist, newly released Boltz-2 targets binding affinity, and combating negativity besieging biotech

BioByte 119: e-tattoos that measure mental workload, introducing Biomni, FrankenROCS identifies drug candidates for Covid, and evolutionary watermarking to trace protein structures with FoldMark